Shots: The P-IIIb Liberty study involves assessing of Aimovig (140 mg) vs PBO @12 wks. in patients with episodic migraine (4 to 14 migraine days/month) P-IIIb LIBERTY study results: reduction in migrane days 50% @1EP (30% vs 14%); reduction in migrane days 75% @2EP (12% vs 4%); migrane free patients 6%; MMD (1.8 vs 0.2) […]Read More
